MarketPeel
Insider Trading Intelligence
BI

Biogen Ma Inc.

SGMO
10% OWNER · SANGAMO THERAPEUTICS, INC · CIK 0001810387
FILING MIX · LIFETIME0%/100%
BUYS
0
SELLS
12
TOTAL VALUE
$7.95M
COMPANIES
1
ACTIVE SINCE
Nov 2021
HOLDINGS NOW
17,652,466
AVG SELL PX
$1.18
TRADE KIND
SHOWING 12 / 12
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
12 backtested trades · 8 horizons
Forward-return performance of every backtestable P/S trade by Biogen Ma Inc., measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d12+75.00%-5.47%-0.02%-5.46%-5.96%
14d12+75.00%-7.23%+0.65%-7.88%-9.39%
30d12+100.00%-17.84%-2.53%-15.31%-18.74%
60d12+100.00%-28.86%-3.44%-25.43%-24.66%
90d12+100.00%-31.50%-3.89%-27.62%-26.18%
180d12+100.00%-48.62%-7.95%-40.67%-45.03%
1y12+91.67%-56.95%-5.34%-51.61%-46.99%
2y12+100.00%-85.43%+14.12%-99.55%-97.09%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
SGMO · 17,652,466 shares · as of Sep 26, 2023
06,097,81812,195,63718,293,45524,391,27320222023SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2021
2022
2022
2022
2022
2023
2023
2023
FLOW · 0 buys / 12 sellsCOVERAGE · 8 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
SGMO
SANGAMO THERAPEUTICS, INC
SALE
6,000,000$0.50$3.00M17,652,466Sep 26, 2023Sep 28, 2023View →
SGMO
SANGAMO THERAPEUTICS, INC
SALE
100,000$5.27$526.5K23,652,466Aug 30, 2022Aug 31, 2022View →
SGMO
SANGAMO THERAPEUTICS, INC
SALE
400,000$5.33$2.13M23,752,466Aug 29, 2022Aug 31, 2022View →
SGMO
SANGAMO THERAPEUTICS, INC
SALE
2,764$8.51$23.5K24,152,466Dec 28, 2021Dec 30, 2021View →
SGMO
SANGAMO THERAPEUTICS, INC
SALE
600$8.56$5.1K24,155,230Dec 27, 2021Dec 28, 2021View →
SGMO
SANGAMO THERAPEUTICS, INC
SALE
81,187$8.55$694.5K24,155,830Dec 23, 2021Dec 28, 2021View →
SGMO
SANGAMO THERAPEUTICS, INC
SALE
23,660$8.56$202.5K24,237,017Dec 9, 2021Dec 10, 2021View →
SGMO
SANGAMO THERAPEUTICS, INC
SALE
75,814$8.64$654.8K24,260,677Dec 8, 2021Dec 9, 2021View →
SGMO
SANGAMO THERAPEUTICS, INC
SALE
52,178$8.52$444.4K24,336,491Dec 7, 2021Dec 9, 2021View →
SGMO
SANGAMO THERAPEUTICS, INC
SALE
1,874$8.51$15.9K24,388,669Dec 2, 2021Dec 3, 2021View →
SGMO
SANGAMO THERAPEUTICS, INC
SALE
730$8.52$6.2K24,390,543Dec 1, 2021Dec 3, 2021View →
SGMO
SANGAMO THERAPEUTICS, INC
SALE
28,884$8.60$248.4K24,391,273Nov 26, 2021Nov 30, 2021View →
Other insiders · SGMO
Loading peer insiders…
About this filer
CIK 0001810387
ROLE
10% Owner
PRIMARY
SGMO
COMPANIES
1
ACTIVE SINCE
Nov 2021
MARKETPEEL · /INSIDER/0001810387DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback